Eupraxia Pharmaceuticals Inc.
EPRX.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 80.56M | 88.96M | 19.77M | 27.45M | 33.10M |
| Total Receivables | 674.20K | 139.90K | 134.60K | 238.50K | 228.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.86M | 2.30M | 2.93M | 913.30K | 1.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 85.10M | 91.40M | 22.83M | 28.61M | 34.44M |
|
|
|||||
| Total Current Assets | 85.10M | 91.40M | 22.83M | 28.61M | 34.44M |
| Net Property, Plant & Equipment | 987.10K | 851.60K | 688.30K | 546.50K | 424.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.30K | 97.60K | 77.80K | 80.20K | 80.80K |
| Total Assets | 86.15M | 92.35M | 23.60M | 29.23M | 34.94M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 5.51M | 3.71M | 2.55M | 2.10M | 3.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 78.50K | 76.10K | 35.10K | 52.80K | 71.90K |
| Total Finance Division Other Current Liabilities | 41.80K | 28.10K | 28.80K | 45.20K | 20.70K |
| Total Other Current Liabilities | 41.80K | 28.10K | 28.80K | 45.20K | 20.70K |
| Total Current Liabilities | 5.63M | 3.81M | 2.62M | 2.20M | 3.10M |
|
|
|||||
| Total Current Liabilities | 5.63M | 3.81M | 2.62M | 2.20M | 3.10M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 75.90K | 94.50K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 0.00 | -- |
| Total Liabilities | 5.70M | 3.91M | 2.62M | 2.20M | 3.10M |
|
|
|||||
| Common Stock & APIC | 223.93M | 214.49M | 140.14M | 138.79M | 136.86M |
| Retained Earnings | -169.58M | -152.87M | -146.51M | -137.77M | -131.00M |
| Treasury Stock & Other | -2.04M | -3.30M | -2.79M | -4.12M | -4.16M |
| Total Common Equity | 52.30M | 58.32M | -9.15M | -3.10M | 1.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 29.74M | 31.71M | 31.71M | 31.71M | 31.71M |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 29.74M | 31.71M | 31.71M | 31.71M | 31.71M |
|
|
|||||
| Total Common Equity | 52.30M | 58.32M | -9.15M | -3.10M | 1.70M |
| Total Preferred Equity | 29.74M | 31.71M | 31.71M | 31.71M | 31.71M |
| Total Minority Interest | -1.60M | -1.59M | -1.58M | -1.57M | -1.57M |
| Total Equity | 80.45M | 88.44M | 20.98M | 27.03M | 31.84M |
|
|
|||||